News about Global Pharma

Cosette Pharma Appoints Brad Leonard as Vice President-Generics Commercial Operation

Brad played a pivotal role in the growth and success of Upsher-Smith Laboratories, LLC using a customer-focused approach to enhance their financial performance and commercial presence - demonstrated by over eight HDMA Diana Awards for product excellence and overall company performance.

Global Pharma | 04/02/2025 | By Aishwarya |  685

Vanda and Anaptys to Develop and Commercialize Imsidolimab

GPP is a rare skin disorder often caused by mutations in the IL36RN gene that codes for a regulatory protein that balances the activity of the proinflammatory IL-36 family of cytokines.

Global Pharma | 04/02/2025 | By Aishwarya |  673

Moberg Pharma AB and Allderma Announce Launch of Terclara in Norway

Moberg Pharma AB and Allderma have announced the launch of Terclara (MOB-015) in Norway, following its success in Sweden, with initial pharmacy deliveries expected in February 2025.

Global Pharma | 03/02/2025 | By Manvi |  645

Alterity Therapeutics Raises AUD 2.13 Million from US Market to Accelerate ATH434 Clinical and BD Activities

Alterity Therapeutics has raised approximately AUD 2.13 million in the US via its at-the-market (ATM) facility and expects to receive around AUD 5.69 million in rebates from the Australian Taxation Office, enabling the acceleration of clinical and business development activities for its lead asset, ATH434.

Global Pharma | 03/02/2025 | By Manvi |  133

Clinigen Announces Collaboration with Tepsivo

At the heart of Tepsivo’s offering is its cutting-edge PV platform and proprietary automated PV software powered by artificial intelligence and other digital innovations.

Global Pharma | 03/02/2025 | By Aishwarya |  314

Cognizant Extends Alliance with Gilead to Boost Advanced Technology Applications

Gilead is expected to enhance its efficiency through leveraging Cognizant's expertise in AI and advanced technology applications.

Global Pharma | 03/02/2025 | By Aishwarya |  498

Union Budget 2025 to Ease Drug Costs with More Medicines Under Assistance Schemes

The Union Budget also expands the list of medicines that will be exempt from Basic Customs Duty under pharmaceutical companies’ Patient Assistance Programmes.

Global Pharma | 01/02/2025 | By Aishwarya |  1235

Kadimastem Shareholders Approve Merger with NLS Pharmaceutics

The merger brings NLS and Kadimastem one step closer to creating a combined Nasdaq-traded biotechnology company with a robust portfolio of advanced therapies for neurodegenerative diseases and diabetes.

Global Pharma | 01/02/2025 | By Abha |  328

OneSource Achieves INR 3,926 Million Revenue in Q3FY25

OneSource demonstrated exceptional profitability with EBITDA reaching INR 1,432 million, an 85 percent increase compared to the previous quarter, resulting in a robust EBITDA margin of 36.5 percent, up by 1,334 basis points quarter-on-quarter.

Global Pharma | 01/02/2025 | By Aishwarya |  916

US FDA Approves New Non-Opioid Treatment for Moderate to Severe Acute Pain

The US FDA has approved Journavx (suzetrigine), a first-in-class non-opioid analgesic, for treating moderate to severe acute pain in adults, marking a significant milestone in pain management alternatives.

Global Pharma | 31/01/2025 | By Manvi |  185